ACQUIRED · 2022
Who Acquired MediFox Dan?
ResMed · $990.1M· 28.3× EBITDA
The acquisition
MediFox Dan was acquired by ResMed in 2022 for $990.1M. The deal was priced at 28.3× EBITDA / 11.90× revenue.
MediFox Dan at time of acquisition
Revenue
$83.0M
EBITDA
$35.0M
Deal value
$990.1M
EV / EBITDA
28.3×
Similar healthcare it acquisitions
- Eucalyptus · acquired by Hims & Hers Health, Inc. in 2026 · $1.15B
- Gleamer SAS · acquired by RadNet, Inc. in 2026 · $251.6M
- HealthEZ · acquired by Blue Cross Blue Shield of New Jersey in 2026 · $360.0M
- Unbound Medicine · acquired by MPS Ltd in 2026 · $16.5M
- AccessOne · acquired by Phreesia, Inc. in 2025 · $160.0M
Run a valuation for a similar healthcare it business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the healthcare it calculator →More on healthcare it valuations
- Healthcare It valuation calculator· head-term variant
- Healthcare It median multiples· real-deal benchmarks
- How to value a healthcare it· long-form guide
Sourced from SEC filings and press reporting. Full deal page.
Citation: ExitValue.ai. (2022). MediFox Dan acquired by ResMed. https://exitvalue.ai/acquired/medifox-dan